参松养心胶囊治疗室性心律失常67例临床研究

目的探讨参松养心胶囊治疗室性心律失常的临床疗效。方法将我院确诊的室性心律失常的患者共134例按就诊顺序随机分为治疗组和对照组,每组各67例,对照组患者根据心律失常类型分别采用盐酸普罗帕酮、倍他乐克或盐酸胺碘酮治疗,治疗组在对照组治疗的基础上服用参松养心胶囊4粒/次,3次/d。治疗1个月后比较两组的心电图疗效和临床疗效。结果治疗组心电图总有效率为91.04%,对照组为76.12%,差异有统计学意义（P〈0.05）;治疗组临床疗效总有效率为92.54%,对照组为77.61%,差异有统计学意义（P〈0.05）。结论参松养心胶囊治疗室性心律失常的临床疗效优于对照组,参松养心胶囊治疗室性心律失常疗效肯定,值得临床推广使用。

Clinical Study of the Effect of Shensong Yangxin Capsule on Arrhythmia Patients

Objective To study the Shensong Yangxin Capsule′s clinical effect on patients with ventricular arrhythmia.Methods 134 patients who were diagnosed ventricular arrhythmia in our hospital were randomly divided into control group and treatment group,each group 67 patients,the control group received propafenone,metoprolol or amiodarone on the basis of the patients′ arrhythmia type,the treatment group received Shensong Yangxin Capsul except receiving the ordinary therapeutic western medicine.Evaluate the effect after 4 weeks′ treatment.Results The treatment group′s ECG therapeutic effect rate was 91.04% and the control group was 76.12%,there was statistical difference between the two groups(P<0.05);The treatment group′s total clinical therapeutic effect rate was 92.54% and the control group was 77.61%,there was statistical difference between the two groups(P<0.05).Conclusion The treatment group′s therapeutic effect is much better than the control group.Shensong Yangxin Capsule′s therapeutic effect on ventricular arrhythmia patients is definite and worthy to be widely used in clinic.